Germany Osteoarthritis Therapeutics Market Size & Outlook

The osteoarthritis therapeutics market in Germany is expected to reach a projected revenue of US$ 362.4 million by 2033. A compound annual growth rate of 8.9% is expected of Germany osteoarthritis therapeutics market from 2026 to 2033.
Revenue, 2025 (US$M)
$180.6
Forecast, 2033 (US$M)
$362.4
CAGR, 2026 - 2033
8.9%
Report Coverage
Germany

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Germany osteoarthritis therapeutics market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Germany osteoarthritis therapeutics market highlights

  • The Germany osteoarthritis therapeutics market generated a revenue of USD 180.6 million in 2025 and is expected to reach USD 362.4 million by 2033.
  • The Germany market is expected to grow at a CAGR of 8.9% from 2026 to 2033.
  • In terms of segment, viscosupplements was the largest revenue generating product in 2025.
  • Adipose Tissue Therapy is the most lucrative product segment registering the fastest growth during the forecast period.


Osteoarthritis therapeutics market data book summary

Market revenue in 2025USD 180.6 million
Market revenue in 2033USD 362.4 million
Growth rate8.9% (CAGR from 2026 to 2033)
Largest segmentViscosupplements
Fastest growing segmentAdipose Tissue Therapy
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationPlatelet-Rich Plasma (PRP) Therapy, Autologous Chondrocyte Implantation (ACI), Including MACI, Adipose Tissue Therapy, BMAC (Bone Marrow Aspirate Concentrate) Therapy, Stem Cell (other), Bone Graft Substitutes, Viscosupplements, Other (Cartilage Resurfacing Products)
Key market players worldwideGlaxoSmithKline Consumer Healthcare (GSK CH India), Sanofi SA, Pfizer Inc, Bayer AG, Zimmer Biomet Holdings Inc, Novartis AG ADR, Anika Therapeutics Inc, Assertio Holdings Inc, Bioventus Inc Class A


Other key industry trends

  • In terms of revenue, Germany accounted for 3.3% of the global osteoarthritis therapeutics market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In Europe, Germany osteoarthritis therapeutics market is projected to lead the regional market in terms of revenue in 2033.
  • Denmark is the fastest growing regional market in Europe and is projected to reach USD 41.3 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Osteoarthritis Therapeutics Market Scope

Osteoarthritis therapeutics market segmentation & scope
Autologous Chondrocyte Implantation (ACI), Including MACI
Stem Cell (other)

Osteoarthritis Therapeutics Market Companies

Name Profile # Employees HQ Website
Assertio Holdings Inc View profile 30 100 South Saunders Road, Suite 300, Lake Forest, IL, United States, 60045 https://www.assertiotx.com
GlaxoSmithKline Consumer Healthcare (GSK CH India) View profile 1001-5000 Gurgaon, Haryana, India, Asia https://india-consumer.gsk.com/
Bioventus Inc Class A View profile 995 4721 Emperor Boulevard, Suite 100, Durham, NC, United States, 27703 https://www.bioventus.com
Anika Therapeutics Inc View profile 357 32 Wiggins Avenue, Bedford, MA, United States, 01730 https://www.anika.com
Bayer AG View profile 99723 Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 https://www.bayer.com
Zimmer Biomet Holdings Inc View profile 18000 345 East Main Street, Warsaw, IN, United States, 46580 https://www.zimmerbiomet.com
Sanofi SA View profile 87994 46, avenue de la Grande Armée, Paris, France, 75017 https://www.sanofi.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
Novartis AG ADR View profile 76057 Lichtstrasse 35, Basel, Switzerland, 4056 https://www.novartis.com

Germany osteoarthritis therapeutics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to osteoarthritis therapeutics market will help companies and investors design strategic landscapes.


Viscosupplements was the largest segment with a revenue share of 72.87% in 2025. Horizon Databook has segmented the Germany osteoarthritis therapeutics market based on platelet-rich plasma (prp) therapy, autologous chondrocyte implantation (aci), including maci, adipose tissue therapy, bmac (bone marrow aspirate concentrate) therapy, stem cell (other), bone graft substitutes, viscosupplements, other (cartilage resurfacing products) covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Germany osteoarthritis therapeutics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Germany osteoarthritis therapeutics market databook

  • Our clientele includes a mix of osteoarthritis therapeutics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Germany osteoarthritis therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into Germany osteoarthritis therapeutics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Germany Viscosupplementation Agents - Osteoarthritis Therapeutics Market size, 2025 - 2033 (US$M)

Germany Osteoarthritis Therapeutics Market Outlook Share, 2025 & 2033 (US$M)

Germany Viscosupplementation Agents - Osteoarthritis Therapeutics Market size, 2025 - 2033 (US$M)

Related statistics

No records

No related statistics found.

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online